StockWatch
·

Concord Biotech Ltd Q3 FY26 Results

CONCORDBIOQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue277.7712.4%13.7%
Total Income287.7410.5%11.1%
Expenditure197.6111.6%23.8%
PBT86.854.2%12.6%
Net Profit63.640.9%16.2%
OPM34.46%1.36pp5.29pp
NPM22.12%2.10pp6.49pp
EPS6.080.8%16.3%
View full financials

Informational and educational content only. Not investment advice.